← Leaderboards
Gary J Nabel
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseHuman TissueEnzyme Linked Immunosorbent AssayTissue /Cell CultureVaccine DevelopmentFlow CytometryTransfection /Expression VectorVector VaccineImmunoprecipitationVirus ProteinBioterrorism /Chemical WarfareViral VaccinesVirus Infection MechanismEbola VirusAdenoviridaeGuinea PigsHemorrhagic FeverAids VaccinesGlycoproteinsImmune Tolerance /UnresponsivenessBiotechnologyVaccine EvaluationVaccinesHiv Infections
Grant awards (55)
HIV/AIDS Vaccine Development$2,367,571
Z01 · FY2007 · AI · contact PI
Influenza Vaccine Development$1,183,785
Z01 · FY2007 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$887,840
Z01 · FY2007 · AI · contact PI
Understanding adenoviral structure and mechanisms of entry into cells$295,946
Z01 · FY2007 · AI · contact PI
Development of Broad-Spectrum Antiviral Agents$295,946
Z01 · FY2007 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells via DC-SIGN$295,946
Z01 · FY2007 · AI · contact PI
The Mechanisms Involved in Ebola Glycoprotein Induced Cytotoxicity$295,946
Z01 · FY2007 · AI · contact PI
Modulating Intracellular Signaling Cascades-Enhance Immu$0
Z01 · FY2006 · AI · contact PI
The Mechanisms Involved in Ebola Glycoprotein Induced Cy$0
Z01 · FY2006 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells v$0
Z01 · FY2006 · AI · contact PI
West Nile Virus Vaccine Development$0
Z01 · FY2006 · AI · contact PI
Ebola Vaccine Development$0
Z01 · FY2006 · AI · contact PI
Influenza Vaccine Development$0
Z01 · FY2006 · AI · contact PI
HIV/AIDS Vaccine Development$0
Z01 · FY2006 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$0
Z01 · FY2006 · AI · contact PI
Development of Broad-Spectrum Antiviral Agents$0
Z01 · FY2006 · AI · contact PI
Development of Broad-Spectrum Antiviral Agents$0
Z01 · FY2005 · AI
Intracellular Signaling Cascades-Enhance Immune Response$0
Z01 · FY2005 · AI
West Nile Virus Vaccine Development$0
Z01 · FY2005 · AI
HIV-1 Entry and Transfer to CD4+ T cells via DC-SIGN$0
Z01 · FY2005 · AI
Mechanisms in Ebola Glycoprotein Induced Cytotoxicity$0
Z01 · FY2005 · AI
SARS Coronavirus Vaccine Development$0
Z01 · FY2005 · AI
Ebola Vaccine Development$0
Z01 · FY2005 · AI
Influenza Vaccine Development$0
Z01 · FY2005 · AI
HIV/AIDS Vaccine Development$0
Z01 · FY2005 · AI
Recombinant Adenovirus Vector Vaccine Studies$0
Z01 · FY2005 · AI
Mechanisms in Ebola Glycoprotein Induced Cytotoxicity$0
Z01 · FY2004 · AI
Recombinant Adenovirus Vector Vaccine Studies$0
Z01 · FY2004 · AI
HIV/AIDS Vaccine Development$0
Z01 · FY2004 · AI
Influenza Vaccine Development$0
Z01 · FY2004 · AI
Ebola Vaccine Development$0
Z01 · FY2004 · AI
Ebola Virology$0
Z01 · FY2004 · AI
SARS Coronavirus Vaccine Development$0
Z01 · FY2004 · AI
West Nile Virus Vaccine Development$0
Z01 · FY2004 · AI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$0
Z01 · FY2004 · AI
RNAi technology to investigate HIV replication$0
Z01 · FY2004 · AI
Immunogenicity of HIV-1 Particles in DNA vaccine$0
Z01 · FY2004 · AI
Recombinant Adenovirus And Poxvirus Vector Vaccine Studi$0
Z01 · FY2003 · AI
RNAi technology using lentiviral delivery systems to inv$0
Z01 · FY2003 · AI
Mechanisms of DC Infection by HIV and HIV Transmission t$0
Z01 · FY2003 · AI
West Nile Virus Vaccine Development$0
Z01 · FY2003 · AI
SARS Coronavirus Vaccine Development$0
Z01 · FY2003 · AI
Mechanisms Of T Cell Differentiation And Immune Response$0
Z01 · FY2003 · AI
Ebola Virology$0
Z01 · FY2003 · AI
Ebola Vaccine Development$0
Z01 · FY2003 · AI
Influenza Vaccine Development$0
Z01 · FY2003 · AI
Hiv/aids Vaccine Development$0
Z01 · FY2003 · AI
Hiv/aids Vaccine Development$0
Z01 · FY2002 · AI
Mechanisms Of T Cell Differentiation And Immune Response$0
Z01 · FY2002 · AI
Ebola Virology$0
Z01 · FY2002 · AI
Immune Suppression: Role Of The Fas/fas Ligand (cd95/cd9$0
Z01 · FY2002 · AI
Immunogenicity Of Sos Plasmid Constructs$0
Z01 · FY2002 · AI
Ebola Vaccine Development$0
Z01 · FY2002 · AI
Influenza Vaccine Development$0
Z01 · FY2002 · AI
Recombinant Adenovirus And Poxvirus Vector Vaccine Studi$0
Z01 · FY2002 · AI